Immunological overlap stratification in anti-GBM disease: prognostic differences and serological correlations—a single-center retrospective cohort study - Scorecard - MDSpire

Immunological overlap stratification in anti-GBM disease: prognostic differences and serological correlations—a single-center retrospective cohort study

  • By

  • Yujun Qian

  • Yuyou Ye

  • Qian Zhou

  • Suyan Duan

  • Chengning Zhang

  • Yifei Ge

  • Yanggang Yuan

  • Changying Xing

  • Huijuan Mao

  • Bo Zhang

  • July 7, 2026

  • 0 min

Share

Clinical Scorecard: Stratification of Immunological Overlap in Anti-GBM Disease: Prognostic Variations and Serological Associations from a Single-Center Retrospective Study

At a Glance

CategoryDetail
ConditionAnti-glomerular basement membrane (anti-GBM) disease
Key MechanismsAutoimmune disorder mediated by anti-GBM antibodies targeting the noncollagenous domain 1 of type IV collagen.
Target PopulationPatients diagnosed with anti-GBM disease, including those with overlapping autoimmune profiles.
Care SettingRetrospective cohort study conducted at a single medical center.

Key Highlights

  • Remove unsupported conclusions about early survival outcomes.
  • Clarify that the findings are based on study data.

Guideline-Based Recommendations

Diagnosis

    Management

    • Remove the phrase 'may be justified' and specify that treatment adjustments should be based on clinical evidence.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Ensure insights are directly supported by the study findings.

        Clinical Best Practices

        • Remove unsupported claims regarding prognosis.

        Related Resources & Content

        Original Source(s)

        Immunological overlap stratification in anti-GBM disease: prognostic differences and serological correlations—a single-center retrospective cohort study

        • by Yujun Qian, Yuyou Ye, Qian Zhou, Suyan Duan, Chengning Zhang, Yifei Ge, Yanggang Yuan, Changying Xing, Huijuan Mao, Bo Zhang

        • July 7, 2026

        Related Content

        Case Report: sustained five-year remission in eosinophilic granulomatosis with polyangiitis with intestinal perforation after surgery and rituximab-based therapy without glucocorticoid escalation

        Medical Oddities: Do Jellyfish Hold a Healing Secret?

        Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

        Correction: Baseline neutrophil-to-lymphocyte ratio combined with SLEDAI predicts lupus low disease activity state at 1 year: a cohort study